BDBM277662 US10072026, Example 8-11::US10072026, Example 8-12::US10072026, Example 8-16::US10947254, Example 8-12::US11780852, Example 8-12

SMILES COc1cccc(C[C@@H]2COc3ccc4ncc(F)cc4c3C(=O)N[C@H](C(=O)NCCc3nc(OC)no3)CC(=O)N(C)[C@@H](CC(C)C)C(=O)N(C)[C@H](Cc3nc(C(F)(F)F)no3)C(=O)N2)n1

InChI Key InChIKey=ZBGAPJKLLCZANK-UHFFFAOYSA-N

Data  20 KI

  Tab Delimited (TSV)   2D SDfile   Computed 3D by Vconf -m prep SDfile
Find this compound or compounds like it in BindingDB:
   Substructure
Similarity at least:  must be >=0.5
Exact match

Activity Spreadsheet -- Enzyme Inhibition Constant Data from BindingDB

Found 1 hit for monomerid = 277662   

TargetCytochrome P450 3A4(Human)
Idorsia Pharmaceuticals

US Patent
LigandChemical structure of BindingDB Monomer ID 277662BDBM277662(US20260098060, Example 23)
Affinity DataIC50: 7.70E+3nMAssay Description:JAK1, JAK2, JAK3 and Tyk2 were purchased from Carna Biosciences, Inc. As the substrate, LANCE Ultra ULight-JAK1 Peptide (manufactured by PerkinElmer ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
8/19/2026
Entry Details
US Patent